Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

Palm Beach, FL – December 26, 2024 – The breast cancer drugs market is experiencing rapid expansion due to the diverse applications of drugs in various breast cancer treatment scenarios. Predominantly utilized before and after surgery, these drugs are pivotal in managing the disease. Significant research efforts are focused on targeted therapies tailored to specific breast cancer […]

Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data

Promising BRACELET-1 results in HR+/HER2- metastatic breast cancer lay the foundation for potential registration-enabling study and accelerated approval   Advancing gastrointestinal cancer pipeline underscores potential for additional registration-enabling studies   SAN DIEGO, CA and CALGARY, AB – December 26, 2024 — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy […]

KULR Launches Bitcoin Treasury with Purchase of 217.18 Bitcoin for $21 Million

Houston, TX – December 26, 2024 – KULR Technology Group, Inc. (NYSE American: KULR) ($KULR) (the “Company” or “KULR”), a leader in advanced energy management platforms, today announced that it has completed the purchase of 217.18 Bitcoin (“BTC”) for approximately $21 million, at an average price of $96,556.53 per BTC.   The purchase follows the […]